160 related articles for article (PubMed ID: 19177288)
1. The use of contrast-enhanced ultrasound in patients with GIST metastases that are negative in CT and PET.
Dietrich C; Hartung E; Ignee A
Ultraschall Med; 2008 Dec; 29 Suppl 5():276-7. PubMed ID: 19177288
[No Abstract] [Full Text] [Related]
2. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
Choi H; Charnsangavej C; Faria SC; Macapinlac HA; Burgess MA; Patel SR; Chen LL; Podoloff DA; Benjamin RS
J Clin Oncol; 2007 May; 25(13):1753-9. PubMed ID: 17470865
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
[TBL] [Abstract][Full Text] [Related]
4. Response evaluation of gastrointestinal stromal tumors.
Choi H
Oncologist; 2008; 13 Suppl 2():4-7. PubMed ID: 18434631
[TBL] [Abstract][Full Text] [Related]
5. Highlighting the role of FDG PET scan in early response assessment of gastrointestinal stromal tumor treated with imatinib mesylate.
Abhyankar SA; Nair N
Clin Nucl Med; 2008 Mar; 33(3):213-4. PubMed ID: 18287851
[No Abstract] [Full Text] [Related]
6. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
[TBL] [Abstract][Full Text] [Related]
7. Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.
Valls-Ferrusola E; García-Garzón JR; Ponce-López A; Soler-Peter M; Fuertes-Cabero S; Moragas-Solanes M; Riera-Gil E; Carrió-Gasset I; Lomeña-Caballero F
Rev Esp Enferm Dig; 2012 Jul; 104(7):360-6. PubMed ID: 22849497
[TBL] [Abstract][Full Text] [Related]
8. CT evaluation of gastrointestinal stromal tumors treated with imatinib mesylate.
Erturk SM
AJR Am J Roentgenol; 2005 Nov; 185(5):1366; author reply 1366-7. PubMed ID: 16247167
[No Abstract] [Full Text] [Related]
9. Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography.
Heinicke T; Wardelmann E; Sauerbruch T; Tschampa HJ; Glasmacher A; Palmedo H
Anticancer Res; 2005; 25(6C):4591-4. PubMed ID: 16334147
[TBL] [Abstract][Full Text] [Related]
10. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy.
Shankar S; Dundamadappa SK; Karam AR; Stay RM; van Sonnenberg E
Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005
[TBL] [Abstract][Full Text] [Related]
11. Resistance to treatment in gastrointestinal stromal tumours: what radiologists should know.
Tirumani SH; Jagannathan JP; Hornick JL; Ramaiya NH
Clin Radiol; 2013 Aug; 68(8):e429-37. PubMed ID: 23622797
[TBL] [Abstract][Full Text] [Related]
12. 18F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review.
Treglia G; Mirk P; Stefanelli A; Rufini V; Giordano A; Bonomo L
Clin Imaging; 2012; 36(3):167-75. PubMed ID: 22542374
[TBL] [Abstract][Full Text] [Related]
13. [Role of FDG PET in the staging, recurrence and treatment response to imatinib (Glivec) in patients with gastrointestinal stromal tumors].
Simó Perdigó M; García Garzón JR; Soler Peter M; Pérez Moure G; López Gandul S; Lomeña Caballero FJ
Rev Esp Med Nucl; 2006; 25(2):80-8. PubMed ID: 16759613
[TBL] [Abstract][Full Text] [Related]
14. Multimodal functional imaging for early response assessment in GIST patients treated with imatinib.
Revheim ME; Hole KH; Bruland OS; Reitan E; Bjerkehagen B; Julsrud L; Seierstad T
Acta Oncol; 2014 Jan; 53(1):143-8. PubMed ID: 23710697
[No Abstract] [Full Text] [Related]
15. The lessons of GIST--PET and PET/CT: a new paradigm for imaging.
Van den Abbeele AD
Oncologist; 2008; 13 Suppl 2():8-13. PubMed ID: 18434632
[TBL] [Abstract][Full Text] [Related]
16. Sonography of multifocal Brucella orchitis.
Domachevsky L; Peled N; Barzilai M
Ultraschall Med; 2008 Dec; 29 Suppl 5():275-6. PubMed ID: 19085749
[No Abstract] [Full Text] [Related]
17. Relationship between FDG uptake and the pathological risk category in gastrointestinal stromal tumors.
Otomi Y; Otsuka H; Morita N; Terazawa K; Furutani K; Harada M; Nishitani H
J Med Invest; 2010 Aug; 57(3-4):270-4. PubMed ID: 20847527
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal stromal tumor with metastases in an adult woman treated with imatinib mesylate: MDCT findings.
Busalacchi PJ; de la Calle MA; Torroba A; Del Río ST
AJR Am J Roentgenol; 2005 Mar; 184(3 Suppl):S58-61. PubMed ID: 15728023
[No Abstract] [Full Text] [Related]
19. PET/CT imaging of gastrointestinal stromal tumor with calcified peritoneal implants after imatinib therapy.
Eslamy HK; Quon A
Clin Nucl Med; 2008 Dec; 33(12):864-5. PubMed ID: 19033789
[TBL] [Abstract][Full Text] [Related]
20. [Early response to treatment with Glivec detected with 18F-FDG PET in a patient with gastrointestinal stromal tumor].
Delgado Bolton RC; Ortega Candil A; Pérez Castejón MJ; Garcerant M; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
Rev Esp Med Nucl; 2008; 27(2):112-7. PubMed ID: 18367049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
